Maximum Dose Calculation for Local Anesthetics

Dose Recommendations by Route of Administration

• The maximum dose of local anesthetic drugs is calculated differently for intravenous administration compared to peripheral nerve blocks, with significantly lower doses recommended for intravenous use due to higher risk of systemic toxicity 1, 2
• For intravenous regional anesthesia (Bier block), the maximum dose of lidocaine should be decreased to 3-5 mg/kg 1, 2
• Long-acting local anesthetics (bupivacaine, ropivacaine, levobupivacaine) should not be used for intravenous regional anesthesia due to increased risk of cardiac toxicity 1, 2
• When administering lidocaine intravenously for analgesia, ideal body weight should be used for dose calculation rather than actual body weight 3
• Maximum doses for peripheral nerve blocks are significantly higher than for intravenous administration 1, 4
• For peripheral nerve blocks, the following maximum doses apply (with epinephrine):
  • Lidocaine: 7.0 mg/kg 1, 4
  • Bupivacaine: 3.0 mg/kg 1, 4
  • Ropivacaine: 3.0 mg/kg 1, 4
  • Mepivacaine: 7.0 mg/kg 1, 4

Important Considerations for Safe Dosing

• Doses of amide local anesthetics should be decreased by 30% in infants younger than 6 months 1, 4
• Lower doses should be used in very vascular areas due to increased systemic absorption 1, 4
• When using epinephrine-containing solutions, the maximum recommended doses are higher due to decreased vascular absorption 1, 4

Prevention of Local Anesthetic Systemic Toxicity (LAST)

• Calculate the maximum allowable safe dosage (mg/kg) before administration 4, 2
• Consider using ideal body weight rather than actual body weight, especially in obese patients 3
• Enhanced sedative effects may occur when high doses of local anesthetics are combined with other sedatives or opioids 4, 2

Common Pitfalls and How to Avoid Them

• Using actual body weight instead of ideal body weight in obese patients 3
• Not accounting for the additive effects when multiple local anesthetics are used concurrently 4, 2
• Overlooking the need for dose reduction in special populations (infants, elderly, patients with organ dysfunction) 1

Local Anesthesia Dosage Guidelines

Maximum Dosage Guidelines by Administration Route

• The American Thoracic Society recommends a maximum total dose of 8.2 mg/kg (approximately 29 ml of 2% solution for a 70 kg patient) for bronchoscopy, with 2% lignocaine gel preferred over spray for nasal anesthesia 5, 6

Intravenous Lidocaine Infusions

• The American Society of Anesthesiologists recommends a loading dose of 1.5 mg/kg given over 10 minutes and a maintenance infusion of 1.5 mg/kg/hour for no longer than 24 hours, with ideal body weight used for calculations 7, 8, 9
• For patients weighing less than 40 kg, intravenous lidocaine infusions should be avoided 7, 8

Important Safety Considerations

• The American Society of Anesthesiologists advises against using intravenous lidocaine within 4 hours of other local anesthetic interventions 9

Special Population Considerations

• The American Thoracic Society suggests using lower doses in elderly patients and those with liver or cardiac impairment 5

Maximum Lidocaine Dose for Children

Weight-Based Dosing Guidelines

• The maximum safe dose of local infiltrative lidocaine for children without epinephrine is 4.5 mg/kg, as recommended by pediatric emergency medicine guidelines, which for a 13kg child translates to 58.5mg maximum 10
• The maximum safe dose of local infiltrative lidocaine for children with epinephrine is 7.0 mg/kg, as recommended by pediatric emergency medicine guidelines, which for a 13kg child translates to 91mg maximum 10
• The American Academy of Dermatology recommends 3.0-4.5 mg/kg with epinephrine for children 11

Critical Safety Considerations

• If the child is under 6 months of age, reduce all amide local anesthetic doses by 30%, which would lower the maximum to approximately 40.9mg without epinephrine or 63.7mg with epinephrine 10
• Always aspirate frequently before injection to avoid intravascular administration, which dramatically increases toxicity risk 10
• Use reduced doses when injecting into highly vascular tissues due to increased systemic absorption 10
• The maximum dose for intravenous regional anesthesia drops dramatically to 3-5 mg/kg, and long-acting agents should never be used intravenously 10

Monitoring for Toxicity

• Early signs of local anesthetic systemic toxicity include seizures or CNS depression 10
• Progressive toxicity manifests as seizures or CNS depression 10, 11
• When using high doses of local anesthetics, document vital signs at least every 5 minutes initially, then every 10-15 minutes once stable 10

Common Pitfalls to Avoid

• Calculate the maximum allowable dose before starting the procedure to avoid cumulative dosing errors 10
• Enhanced sedative effects occur when maximum recommended doses of local anesthetics are combined with opioids or other sedatives 10

Maximum Dose of Lidocaine for Local Anesthesia

Adult Dosing Guidelines

• The American Academy of Dermatology recommends administering no more than 4.5 mg/kg of lidocaine without epinephrine or 7.0 mg/kg of lidocaine with epinephrine in a single treatment for adults undergoing local infiltrative anesthesia 12
• For standard local infiltration, the maximum dose is 4.5 mg/kg without epinephrine and 7.0 mg/kg with epinephrine, based on expert consensus and manufacturer recommendations 12, 13, 14
• In multistage procedures, such as Mohs surgery, the maximum dose is 500 mg (50 mL of 1% lidocaine solution) delivered incrementally over several hours, with Level II evidence 12, 13, 14

Pediatric Dosing Guidelines

• Children require substantially lower doses of lidocaine, with a maximum of 1.5-2.0 mg/kg without epinephrine and 3.0-4.5 mg/kg with epinephrine 12, 13, 14

Critical Safety Measures to Prevent Toxicity

• The American Academy of Dermatology recommends calculating the maximum allowable dose in milligrams before starting the procedure and using the lowest effective dose necessary 12
• Aspirate before each injection to avoid intravascular administration, and use incremental injections rather than bolus dosing 12
• Continuously assess and communicate with the patient, and watch for early signs of toxicity, such as circumoral numbness, facial tingling, and metallic taste 12, 15

Important Clinical Considerations

• Epinephrine significantly increases safety margins by decreasing systemic absorption, allowing 55% higher doses (7.0 vs 4.5 mg/kg) 12, 13
• The American Academy of Dermatology recommends using concentrations of 2.5-5 μg/mL when administering large doses 12, 13

Common Pitfalls and How to Avoid Them

• Convert concentrations correctly: 1% lidocaine = 10 mg/mL, and calculate doses using ideal body weight, not actual body weight 15
• Track total dose administered over time, and avoid cumulative dosing in prolonged procedures 12, 15
• Account for additive effects when using multiple local anesthetics, and consider the total dose of all local anesthetics 16

Needle Length and Insertion Angle for Lidocaine Skin Infiltration

Needle Length

• For most superficial skin infiltration procedures in adult patients, a standard needle length of 25 mm (1 inch) is appropriate, providing sufficient depth for effective anesthesia without unnecessary tissue penetration. 17

Insertion Technique

• The needle should be introduced at an angle of approximately 25 degrees to the skin surface for superficial infiltration, facilitating smooth entry and reducing procedural discomfort. 17

Intraosseous Lidocaine Use and Safety in Pediatric Patients

Therapeutic IO Lidocaine Dosing

• For pediatric patients requiring intraosseous (IO) medication during resuscitation, lidocaine can be administered IO for arrhythmia treatment at 1 mg per kilogram of body weight, with an absolute maximum of 100 mg. This dosing is intended for systemic anti‑arrhythmic effect, not for local infiltration at the insertion site. 18

Limits for Topical Lidocaine Application

• When lidocaine is applied topically for airway management in children, the maximum recommended dose is 5–7 mg per kilogram of body weight. Exceeding this limit contributes to cumulative local anesthetic exposure. 19

Cumulative Dose Management

• The total lidocaine exposure from all sources (topical, infiltrative, regional, or IO systemic administration) must not exceed 4.5 mg per kilogram when epinephrine is not used. This ceiling helps prevent Local Anesthetic Systemic Toxicity (LAST) in pediatric patients. [20][21]22

Emergency Preparedness for Local Anesthetic Toxicity

• In settings where lidocaine is administered, flumazenil and naloxone should be immediately available to reverse potential sedative or opioid effects that may be potentiated by high local anesthetic doses. 19